Get early access! Join the Twelve Data AI Assistant waitlist now.

VRTX

387.76999 USD
13.31
3.55%
Last update Aug 12, 3:59 PM EDT
Market closed
Day range
375
388.25
Previous close
374.45999
Open
377.60501
Access this stock data via API
Subscribe
Vertex Pharmaceuticals Inc.
387.77
13.31
3.55%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 3.0B 2.8B 2.9B 2.8B
Cost of revenue 407.5M 363M 423.4M 392.6M
Gross profit 2.6B 2.4B 2.5B 2.4B
Operating expense
Research & development 978.4M 979.7M 5.6B 875.9M
Selling general and admin 424.6M 396.4M 377.6M 371.8M
Other operating expenses
Operating income 1.2B 1.0B -3.5B 1.1B
Non operating interest income
Income 122.4M 120.9M 128.2M 132.2M
Expense 3.7M 3M 2.8M 7.5M
Other income expense 10.1M -418.6M 4.5B -32.2M
Pretax income 1.3B 730.4M 1.1B 1.2B
Tax provision 250.1M 84.1M 223.5M 178.7M
Net income 1.0B 646.3M 913M 1.0B
Basic EPS 4.0 2.5 3.6 4.1
Diluted EPS 4.0 2.5 3.5 4.0
Basic average shares 256.7M 256.9M 257.5M 258M
Diluted average shares 258.9M 259.5M 260.5M 261M
EBITDA 1.3B 1.2B -3.4B 1.3B
Net income from continuing op. 1.0B 646.3M 913M 1.0B
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 50 minutes

20:09
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).